Needham analyst Mayank Tandon reiterates AgileThought (NASDAQ:AGIL) with a Buy and maintains $7 price target.
Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) has agreed to make a $25 million equity investment in Enalare Therapeutics Inc. The investment consists of upfront…